In briefBMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7515.472 (Published 01 September 2005) Cite this as: BMJ 2005;331:472
FDA postpones approval of emergency contraceptive: After promising a decision by 1 September on the long delayed approval of the over the counter emergency contraceptive known as Plan B, the US Food and Drug Administration has called for a 60 day comment period and has not set a date for a decision, leading to protests from women's health and reproductive …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial